What's Happening?
Nature's npj Parkinson's Disease journal has announced a call for papers focusing on cognitive impairment across the Parkinson's Disease trajectory, from mild cognitive impairment to dementia. The journal seeks mechanistic and biomarker-driven studies
that explore how neural systems support cognitive abilities, leveraging multimodal neuroimaging, genetics, and computational modeling. The collection aims to publish original research articles, reviews, and perspectives, managed by the journal's editorial board members. Submissions are open to all authors, provided they fall within the scope of the collection and adhere to the journal's peer review process.
Why It's Important?
Cognitive impairment is a significant concern in Parkinson's Disease, affecting patients' quality of life and complicating treatment. By encouraging research that clarifies the neural mechanisms underlying cognitive abilities, the journal aims to advance understanding and improve therapeutic strategies. This initiative could lead to the development of new biomarkers for early diagnosis and targeted interventions, potentially slowing disease progression and enhancing patient care. The focus on rigorous phenotyping and trial design reflects the need for precise and effective research methodologies in addressing cognitive challenges in Parkinson's Disease.
